We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $610M
1-Year Est. Return 40.86%
This Fund
S&P 500
This Quarter Est. Return
-0.46%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$23.5M
Cap. Flow
+$24.2M
Cap. Flow %
15.17%
Top 10 Hldgs %
62.97%
Holding
41
New
12
Increased
6
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$20.1M
2
TLGT
Teligent, Inc
TLGT
+$7.87M
3
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$7.2M
4
CI icon
Cigna
CI
+$6.26M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.44M

Top Sells

Rank Stock Value
1
CMRX
Chimerix, Inc.
CMRX
+$6.85M
2
QURE icon
uniQure
QURE
+$5.47M
3
CNC icon
Centene
CNC
+$4.97M
4
RXDX
Ignyta, Inc.
RXDX
+$4.58M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$4.5M

Sector Composition

Rank Sector Weight
1 Healthcare 79.75%
2 Real Estate 6.42%
3 Consumer Discretionary 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KND
26
DELISTED
Kindred Healthcare
KND
$1.49M 0.93%
+162,326
New +$1.5M
NBRV
27
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.22M 0.77%
971
-995
-51% -$1.47M
NVLN
28
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$816K 0.51%
233,003
-63,485
-21% -$269K
QURE icon
29
uniQure
QURE
$2.68B
$801K 0.5%
34,100
-250,617
-88% -$5.47M
BLCM
30
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$696K 0.44%
10,605
-19,530
-65% -$1.47M
AMPE
31
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$378K 0.24%
+371
New +$311K
ACHC icon
32
Acadia Healthcare
ACHC
$3.17B
– –
-26,916
Closed -$878K
EFOR
33
PUT
Everforth Inc
EFOR
$845M
– –
-25,700
Closed -$1.65M
LPCN icon
34
Lipocine
LPCN
$17.1M
– –
-21,947
Closed -$1.28M
RARE icon
35
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-44,600
Closed -$2.07M
CMRX
36
DELISTED
Chimerix, Inc.
CMRX
– –
-1,478,519
Closed -$6.85M
CFMS
37
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-16,000
Closed -$952K
RDUS
38
DELISTED
Radius Health, Inc.
RDUS
– –
-110,000
Closed -$3.5M
ADMS
39
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-12,000
Closed -$407K
ELGX
40
DELISTED
Endologix Inc
ELGX
– –
-65,582
Closed -$3.51M
RXDX
41
DELISTED
Ignyta, Inc.
RXDX
– –
-171,352
Closed -$4.58M
1
2

Similar funds

PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return
BFC
Blue Fin Capital Warren, Rhode Island $610M AUM 26.46% 1-Year Est. Return
DCM
DGS Capital Management Jersey City, New Jersey $609M AUM 44.78% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return
CBB
Citizens Business Bank Ontario, California $610M AUM 27.86% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
CIP
Convergence Investment Partners Palm Beach Gardens, Florida $611M AUM 61.48% 1-Year Est. Return

Prosight Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prosight Management held 41 positions worth $159M, up 17% from $136M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Prosight Management deployed $24.2M of net new capital in Q1 2018, opening 12 new positions and adding to 6 existing holdings. Its largest new stake was Shire pic: 146,114 shares worth $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 79% a quarter earlier, followed by Real Estate and Consumer Discretionary.

On the sell side, the largest reduction was uniQure, an estimated $5.47M trimmed.

  • Prosight Management's largest Q1 2018 buy was Shire pic: 146,114 shares worth $21.8M.
  • Prosight Management added most to Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2018, an estimated $3.21M increase.
  • Prosight Management's biggest Q1 2018 reduction was uniQure, cutting an estimated $5.47M.
  • Prosight Management fully exited Chimerix, Inc. in Q1 2018, selling an estimated $6.85M.
  • Prosight Management's ten largest holdings make up 63% of its $159M portfolio in Q1 2018.
  • Prosight Management opened 12 new positions and closed 10 in Q1 2018.
  • Prosight Management's portfolio value rose 17% quarter-over-quarter to $159M.

Based on Prosight Management's 13F filing for Q1 2018, filed 14 May 2018.